Eckert & Ziegler has begun construction of a production facility for cyclotron-based PET radiopharmaceuticals in Warsaw, Poland.
GE Healthcare and NXT2B, a privately owned venture capital company started in 2011, have entered into a joint financing agreement with the goal of developing a micro-scale radiotracer infrastructure including cyclotron and PET tracer production.
CA Proton Therapy, A ProCure Center, located on Northwest Hospital & Medical Center’s campus in Seattle, has installed a cyclotron, which is used in proton therapy to accelerate protons to create a beam of energy that delivers treatments to cancer patients.
Positron has acquired all of the assets and business operations and retained all employees of Manhattan Isotope Technology (MIT). In exchange, MIT will receive cash advances, assumption of certain indebtedness and earn-out consideration of $3.5 million, based on 20 percent of the net income from sales relating to radioisotope and radiopharmaceutical operations of MIT.
Provision Healthcare has signed an agreement with Ion Beam Applications (IBA) for the purchase, installation and maintenance of a new proton therapy system at Tennessee’s first proton beam cancer center, located in Knoxville.
The first U.S. installation of a newly designed, single-room Proton Therapy technology from IBA (Ion Beam Applications) will be at a proton facility being developed by Willis-Knighton Cancer Center in Shreveport, La.
McMaster University in Hamilton, Ontario, has unveiled its newly expanded Nuclear Research Building, which includes a new cyclotron facility and improvements to the McMaster Nuclear Reactor (MNR) Building.
Positron, a molecular imaging company specializing in nuclear cardiology, has relocated its PosiRx manufacturing, product research and development facility. The new office is approximately three miles from its current Fishers, Ind., location.
Michigan State University (MSU) will work with Cardinal Health to open a new radio-pharmacy on campus, allowing access to nuclear imaging agents created at MSU’s medical cyclotron, according to a press release from MSU.
PET imaging is showing a 7 percent average annual growth rate from 2008 to 2010, which is a decrease from the average annual rate of 10.4 percent from 2005 to 2008, according to IMV's research report, 2011 PET Market Summary Report.
Cardinal Health has opened its first cyclotron facility in the state of Georgia, expanding its capability to manufacture molecular imaging biomarkers that aid in the early diagnosis, monitoring and treatment of cancer, neurological disorders and heart disease.
Positron, a nuclear cardiology company, has executed a memorandum of understanding with the City of Noblesville, Ind., to relocate its corporate headquarters, research & development and product manufacturing facilities to Noblesville.
|
RSS 
